Divalproex Sodium
NDC 71610-031, Divalproex Sodium, tablet, delayed release, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-031
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078182
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIVALPROEX SODIUM250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-031-60 | 71610003160 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (71610-031-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b74adc5e-e92d-46a7-afdc-a6464a440bde
Use it
Look up 71610-031 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.